|
|
Volumn 14, Issue 12, 2015, Pages 807-809
|
|
The phenotypic screening pendulum swings
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
COMPACTIN;
LMI 070;
MAMMALIAN TARGET OF RAPAMYCIN;
MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR;
MEVINOLIN;
MONOCLONAL ANTIBODY;
PHOSPHOTRANSFERASE INHIBITOR;
PITAVASTATIN;
PROTEIN INHIBITOR;
RG 7800;
SIMVASTATIN;
UNCLASSIFIED DRUG;
DNA MODIFICATION;
DRUG APPROVAL;
DRUG EFFICACY;
DRUG RECEPTOR BINDING;
DRUG SCREENING;
DRUG TARGETING;
FOOD AND DRUG ADMINISTRATION;
GENE SILENCING;
HUMAN;
PHASE 2 CLINICAL TRIAL (TOPIC);
PHENOTYPE;
PHENOTYPIC SCREENING;
PLURIPOTENT STEM CELL;
PRIMARY CELL LINE;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
SCIENTIST;
SHORT SURVEY;
SPINAL MUSCULAR ATROPHY;
DRUG DEVELOPMENT;
DRUG INDUSTRY;
ETHICS;
GENE THERAPY;
GENETIC ASSOCIATION;
GENETIC SCREENING;
PHARMACOGENETICS;
PROCEDURES;
TRENDS;
DRUG DISCOVERY;
DRUG INDUSTRY;
GENETIC TESTING;
GENETIC THERAPY;
GENOME-WIDE ASSOCIATION STUDY;
HUMANS;
PHARMACOGENETICS;
PHENOTYPE;
|
|
EID: 84948660289
PISSN: 14741776
EISSN: 14741784
Source Type: Journal
DOI: 10.1038/nrd4783 Document Type: Short Survey |
|
Times cited : (32)
|
|
References (0)
|
